We are live on ! Find out more
ELGX

Endologix Inc
ELGX

Delisted

ELGX was delisted on the 15th of July, 2020.

111 hedge funds and large institutions have $431M invested in Endologix Inc in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 33 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 33

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

14% less funds holding

Funds holding: 129111 (-18)

37% less capital invested

Capital invested by funds: $688M → $431M (-$257M)

56% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 32

99% less call options, than puts

Call options by funds: $7K | Put options by funds: $639K

Holders
111
Holders Change
-18
Holders Change %
-13.95%
% of All Funds
2.77%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
14
Increased
40
Reduced
33
Closed
32
Calls
$7K
Puts
$639K
Net Calls
-$632K
Net Calls Change
-$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
WAM
101
Wealthspire Advisors (Maryland)
Maryland
$10K
Bank of Montreal
102
Bank of Montreal
Ontario, Canada
$7K -$4.71K -80 -36%
Creative Planning
103
Creative Planning
Kansas
$7K -$2.36K -40 -21%
DADC
104
D.A. Davidson & Co
Montana
$4K
Royal Bank of Canada
105
Royal Bank of Canada
Ontario, Canada
$2K -$22K -373 -88%
PNC Financial Services Group
106
PNC Financial Services Group
Pennsylvania
$2K -$18.8K -319 -86%
LTFS
107
Ladenburg Thalmann Financial Services
Florida
$2K
FDCDDQ
108
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.1K
Group One Trading
109
Group One Trading
Illinois
$1K +$1K +17 New
Walleye Trading
110
Walleye Trading
New York
$368 +$446K +7,579 New
TCM
111
TimesSquare Capital Management
New York
-$27.6M -381,467 Closed
GTC
112
Ghost Tree Capital
New York
-$9.41M -130,000 Closed
T. Rowe Price Associates
113
T. Rowe Price Associates
Maryland
-$6.35M -87,763 Closed
KCM
114
Kennedy Capital Management
Missouri
-$4.63M -63,921 Closed
AAMU
115
Amundi Asset Management US
Massachusetts
-$4.56M -63,031 Closed
Point72 Asset Management
116
Point72 Asset Management
Connecticut
-$4.51M -62,240 Closed
Renaissance Technologies
117
Renaissance Technologies
New York
-$3.65M -50,389 Closed
State of Wisconsin Investment Board
118
State of Wisconsin Investment Board
Wisconsin
-$2.9M -40,000 Closed
Citadel Advisors
119
Citadel Advisors
Florida
-$2.52M -34,846 Closed
ECM
120
Endurant Capital Management
California
-$2.42M -33,501 Closed
Fidelity Investments
121
Fidelity Investments
Massachusetts
-$2.17M -30,000 Closed
1CM
122
1492 Capital Management
Wisconsin
-$1.5M -20,753 Closed
RCAMU
123
Rothschild & Co Asset Management US
Connecticut
-$1.12M -15,524 Closed
IHM
124
Iguana Healthcare Management
New York
-$1.09M -15,000 Closed
PGCM
125
Prescott Group Capital Management
Oklahoma
-$943K -13,030 Closed

ELGX Hedge Fund Activity: Q2 2017 in Review

111 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Endologix Inc (ELGX) for Q2 2017, worth a combined $431M — down 37% from $688M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of ELGX and 14 opened new positions — a net loss of 18 holders — while 33 trimmed existing stakes and 40 added.

The largest buyer was Redmile Group, adding an estimated $21.5M. The largest seller was TimesSquare Capital Management, exiting entirely with an estimated $27.6M sold.

  • 111 institutional investors held Endologix Inc (ELGX) as of Q2 2017, down from 129 in Q1 2017.
  • Funds reported $431M of Endologix Inc stock for Q2 2017, down 37% quarter-over-quarter.
  • 14 funds opened new Endologix Inc positions in Q2 2017 and 32 closed out, a net change of -18 holders.
  • The largest Endologix Inc buyer in Q2 2017 was Redmile Group, an estimated $21.5M added.
  • The largest Endologix Inc seller in Q2 2017 was TimesSquare Capital Management, an estimated $27.6M sold.

Based on aggregated 13F filings for Q2 2017.